Cunting, Rowena H.
HRN: 24-10-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2023
CEFUROXIME 1.5GM (VIAL)
12/02/2023
12/08/2023
IV
1.5 G
Q8
S/P CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes